vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Shimmick Corp（SHIM）财务数据对比。点击上方公司名可切换其他公司
Shimmick Corp的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.9倍（$141.9M vs $75.5M），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-28.7M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -10.1%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Shimmick Corp是一家总部位于美国的重型民用建筑企业，专注于水处理设施、交通系统、大坝工程、环境修复等关键公共基础设施的建造与升级，主要服务北美各级政府客户，承接各类复杂大型建筑项目。
PBYI vs SHIM — 直观对比
营收规模更大
SHIM
是对方的1.9倍
$75.5M
自由现金流更多
PBYI
多$43.1M
$-28.7M
两年增速更快
PBYI
近两年复合增速
-10.1%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $141.9M |
| 净利润 | — | $-4.4M |
| 毛利率 | 69.3% | 7.6% |
| 营业利润率 | 22.7% | -2.2% |
| 净利率 | — | -3.1% |
| 营收同比 | 27.7% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.26 | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISHIM
| Q4 25 | $75.5M | $141.9M | ||
| Q3 25 | $54.5M | $128.4M | ||
| Q2 25 | $52.4M | $122.1M | ||
| Q1 25 | $46.0M | $103.6M | ||
| Q4 24 | $59.1M | — | ||
| Q3 24 | $80.5M | $166.0M | ||
| Q2 24 | $47.1M | $90.6M | ||
| Q1 24 | $43.8M | $120.0M |
净利润PBYISHIM
| Q4 25 | — | $-4.4M | ||
| Q3 25 | $8.8M | $-8.5M | ||
| Q2 25 | $5.9M | $-9.8M | ||
| Q1 25 | $3.0M | $-38.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $-1.6M | ||
| Q2 24 | $-4.5M | $-51.4M | ||
| Q1 24 | $-4.8M | $-33.3M |
毛利率PBYISHIM
| Q4 25 | 69.3% | 7.6% | ||
| Q3 25 | 77.7% | 6.3% | ||
| Q2 25 | 76.5% | 3.8% | ||
| Q1 25 | 77.1% | -20.1% | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | 7.3% | ||
| Q2 24 | 77.4% | -34.4% | ||
| Q1 24 | 75.5% | -13.2% |
营业利润率PBYISHIM
| Q4 25 | 22.7% | -2.2% | ||
| Q3 25 | 17.6% | -5.5% | ||
| Q2 25 | 12.7% | -7.3% | ||
| Q1 25 | 8.7% | -39.3% | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | 0.7% | ||
| Q2 24 | -4.6% | -53.0% | ||
| Q1 24 | -5.3% | -26.5% |
净利率PBYISHIM
| Q4 25 | — | -3.1% | ||
| Q3 25 | 16.2% | -6.6% | ||
| Q2 25 | 11.2% | -8.0% | ||
| Q1 25 | 6.5% | -37.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | -0.9% | ||
| Q2 24 | -9.6% | -56.7% | ||
| Q1 24 | -11.0% | -27.8% |
每股收益（稀释后）PBYISHIM
| Q4 25 | $0.26 | $-0.12 | ||
| Q3 25 | $0.17 | $-0.25 | ||
| Q2 25 | $0.12 | $-0.28 | ||
| Q1 25 | $0.06 | $-0.92 | ||
| Q4 24 | $0.40 | — | ||
| Q3 24 | $0.41 | $-0.05 | ||
| Q2 24 | $-0.09 | $-1.83 | ||
| Q1 24 | $-0.10 | $-1.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $17.6M |
| 总债务越低越好 | $22.7M | $57.5M |
| 股东权益账面价值 | $130.3M | $-52.7M |
| 总资产 | $216.3M | $218.5M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYISHIM
| Q4 25 | $97.5M | $17.6M | ||
| Q3 25 | $94.4M | $21.4M | ||
| Q2 25 | $96.0M | $16.3M | ||
| Q1 25 | $93.2M | $33.7M | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | $26.0M | ||
| Q2 24 | $96.8M | $22.4M | ||
| Q1 24 | $107.2M | $27.3M |
总债务PBYISHIM
| Q4 25 | $22.7M | $57.5M | ||
| Q3 25 | $34.0M | $36.4M | ||
| Q2 25 | $45.3M | $31.4M | ||
| Q1 25 | $56.7M | $9.5M | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | $39.9M | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | $31.5M |
股东权益PBYISHIM
| Q4 25 | $130.3M | $-52.7M | ||
| Q3 25 | $115.3M | $-49.5M | ||
| Q2 25 | $104.7M | $-42.6M | ||
| Q1 25 | $97.1M | $-34.7M | ||
| Q4 24 | $92.1M | — | ||
| Q3 24 | $71.1M | $973.0K | ||
| Q2 24 | $48.5M | $436.0K | ||
| Q1 24 | $51.0M | $38.1M |
总资产PBYISHIM
| Q4 25 | $216.3M | $218.5M | ||
| Q3 25 | $202.9M | $203.0M | ||
| Q2 25 | $194.9M | $227.7M | ||
| Q1 25 | $196.2M | $233.9M | ||
| Q4 24 | $213.3M | — | ||
| Q3 24 | $220.7M | $346.7M | ||
| Q2 24 | $205.0M | $344.5M | ||
| Q1 24 | $214.1M | $378.0M |
负债/权益比PBYISHIM
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | 41.01× | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-23.7M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $-28.7M |
| 自由现金流率自由现金流/营收 | 19.1% | -20.2% |
| 资本支出强度资本支出/营收 | 0.0% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $-27.2M |
8季度趋势，按日历期对齐
经营现金流PBYISHIM
| Q4 25 | $14.4M | $-23.7M | ||
| Q3 25 | $9.7M | $-3.8M | ||
| Q2 25 | $14.1M | $-38.2M | ||
| Q1 25 | $3.6M | $44.9M | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | $12.7M | ||
| Q2 24 | $1.0M | $-43.9M | ||
| Q1 24 | $11.2M | $-35.0M |
自由现金流PBYISHIM
| Q4 25 | $14.4M | $-28.7M | ||
| Q3 25 | $9.7M | $-4.2M | ||
| Q2 25 | $14.1M | $-38.7M | ||
| Q1 25 | $3.6M | $44.4M | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | $10.3M | ||
| Q2 24 | $1.0M | $-46.8M | ||
| Q1 24 | — | $-39.6M |
自由现金流率PBYISHIM
| Q4 25 | 19.1% | -20.2% | ||
| Q3 25 | 17.7% | -3.2% | ||
| Q2 25 | 26.8% | -31.7% | ||
| Q1 25 | 7.7% | 42.9% | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | 6.2% | ||
| Q2 24 | 2.1% | -51.7% | ||
| Q1 24 | — | -33.0% |
资本支出强度PBYISHIM
| Q4 25 | 0.0% | 3.5% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.1% | 0.5% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 1.4% | ||
| Q2 24 | 0.0% | 3.3% | ||
| Q1 24 | 0.0% | 3.8% |
现金转化率PBYISHIM
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
SHIM
| Shimmick Projects | $106.8M | 75% |
| Non Core Projects | $35.1M | 25% |
